Mandolin, a platform that makes use of AI automation to reinforce entry to specialty medicine, has introduced it secured $40 million in funding.
Maverick, SignalFire, SV Angel, Greylock Companions, Jerry Yang (cofounder of Yahoo) and Guillermo Rauch (CEO of Vercel) participated within the spherical.
WHAT IT DOES
Mandolin gives an AI-enabled workflow automation platform to be used within the administrative aspect of specialty medicine. Its AI brokers help with consumption, prior authorizations, advantages and income cycle administration.
The San Francisco-based firm says its platform integrates into EHRs, producer hubs and payer portals.
Mandolin launched its product in January and touts that it’s deployed in additional than 700 scientific places.
“We’ll use this capital to develop the crew, primarily specializing in world-class engineering and buyer implementation expertise with the intention to extra deeply serve the wants of our subtle prospects,” Will Yin, cofounder and CEO of Mandolin, advised MobiHealthNews in an e-mail.
MARKET SNAPSHOT
Whole spending on specialty medicine elevated from 21.7% in 2012 to 71.1% in 2021, in response to a examine printed within the Journal of Managed Care and Specialty Pharmacy. Specialty medicine accounted for six.2% of prescriptions however 71.1% of whole spending in 2021.
Different digital well being corporations working within the specialty drug area embrace Serve You Rx, a pharmacy profit supervisor, which in Could introduced a collaboration with Amazon Pharmacy to supply residence supply companies for upkeep medicine to its members.
Serve You Rx members can entry widespread drugs, and specialty sufferers can use Waltz Well being’s AI-powered platform to entry their specialty medicine.
In April, Mark Cuban Price Plus Medicine introduced a collaboration with specialty pharmaceutical distributor Morris & Dickson to offer entry to injectable drugs through the Price Plus Market.
California-based SamaCare gives a workflow platform for suppliers providing specialty medicine. Final 12 months, the corporate secured $17 million in an oversubscribed Sequence B funding spherical.
